Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2015:2015:325851.
doi: 10.1155/2015/325851. Epub 2015 Mar 22.

Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel-group, randomized, open label study in patients with type 2 diabetes in pregnancy

Jahan Ara Ainuddin  1 , Nasim Karim  2 , Sidra Zaheer  3 , Syed Sanwer Ali  4 , Anjum Ara Hasan  5
Affiliations
Randomized Controlled Trial

Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel-group, randomized, open label study in patients with type 2 diabetes in pregnancy

Jahan Ara Ainuddin et al. J Diabetes Res. 2015.

Abstract

Aims: To assess the effect of metformin and to compare it with insulin treatment in patients with type 2 diabetes in pregnancy in terms of perinatal outcome, maternal complications, additional insulin requirement, and treatment acceptability.

Methods: In this randomized, open label study, 206 patients with type 2 diabetes in pregnancy who met the eligibility criteria were selected from the antenatal clinics. Insulin was added to metformin treatment when required, to maintain the target glycemic control. The patients were followed up till delivery. Maternal, and perinatal outcomes and pharmacotherapeutic characteristics were recorded on a proforma.

Results: Maternal characteristics were comparable in metformin and insulin treated group. 84.9% patients in metformin group required add-on insulin therapy at mean gestational age of 26.58 ± 3.85 weeks. Less maternal weight gain (P < 0.001) and pregnancy induced hypertension (P = 0.029) were observed in metformin treated group. Small for date babies were more in metformin group (P < 0.01). Neonatal hypoglycemia was significantly less and so was NICU stay of >24 hours in metformin group (P < 0.01). Significant reduction in cost of treatment was found in metformin group.

Conclusion: Metformin alone or with add-on insulin is an effective and cheap treatment option for patients with type 2 diabetes in pregnancy. This trial is registered with clinical trial registration number: Clinical trials.gov NCT01855763.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow diagram of study enrollment.
See this image and copyright information in PMC

References

    1. Spellman C. W. Pathophysiology of type 2 diabetes: targeting islet cell dysfunction. The Journal of the American Osteopathic Association. 2010;110(3):S2–S7. - PubMed
    1. Crawther C. A., Hiller J. E., Moss R. J., et al. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. The New England Journal of Medicine. 2005;352(24):2477–2486. - PubMed
    1. Inzucchi S. E., Bergenstal R. M., Buse J. B., et al. Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the study of diabetes (EASD) Diabetologia. 2012;55(6):1577–1597. - PubMed
    1. Hawthorne G. Metformin use and diabetic pregnancy—has its time come? Diabetic Medicine. 2006;23(3):223–227. doi: 10.1111/j.1464-5491.2006.01856.x. - DOI - PubMed
    1. Caballero A. E., Delgado A., Aguilar-Salinas C. A., et al. The differential effects of metformin on markers of endothelial activation and inflammation in subjects with impaired glucose tolerance: a placebo-controlled, randomized clinical trial. Journal of Clinical Endocrinology and Metabolism. 2004;89(8):3943–3948. doi: 10.1210/jc.2004-0019. - DOI - PubMed

Publication types

Associated data